Esben Agerbo1, Patrick F Sullivan2, Bjarni J Vilhjálmsson3, Carsten B Pedersen1, Ole Mors4, Anders D Børglum5, David M Hougaard6, Mads V Hollegaard6, Sandra Meier7, Manuel Mattheisen8, Stephan Ripke9, Naomi R Wray10, Preben B Mortensen1. 1. Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark2National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark3Centre for Integrated Register-Based Research, Aarhus University, Aarhus, Denmark. 2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden5Department of Genetics, University of North Carolina at Chapel Hill. 3. Bioinformatic Research Centre, Aarhus University, Aarhus, Denmark. 4. Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark7Department P, Aarhus University Hospital, Risskov, Denmark. 5. Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark7Department P, Aarhus University Hospital, Risskov, Denmark8Department of Biomedicine and Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark. 6. Danish Center for Neonatal Screening, Statens Serum Institut, Copenhagen, Denmark. 7. Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark2National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark. 8. Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark. 9. Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston11Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge. 10. The Queensland Brain Institute, University of Queensland, St Lucia, Australia.
Abstract
IMPORTANCE: Schizophrenia has a complex etiology influenced both by genetic and nongenetic factors but disentangling these factors is difficult. OBJECTIVE: To estimate (1) how strongly the risk for schizophrenia relates to the mutual effect of the polygenic risk score, parental socioeconomic status, and family history of psychiatric disorders; (2) the fraction of cases that could be prevented if no one was exposed to these factors; (3) whether family background interacts with an individual's genetic liability so that specific subgroups are particularly risk prone; and (4) to what extent a proband's genetic makeup mediates the risk associated with familial background. DESIGN, SETTINGS, AND PARTICIPANTS: We conducted a nested case-control study based on Danish population-based registers. The study consisted of 866 patients diagnosed as having schizophrenia between January 1, 1994, and December 31, 2006, and 871 matched control individuals. Genome-wide data and family psychiatric and socioeconomic background information were obtained from neonatal biobanks and national registers. Results from a separate meta-analysis (34,600 cases and 45,968 control individuals) were applied to calculate polygenic risk scores. EXPOSURES: Polygenic risk scores, parental socioeconomic status, and family psychiatric history. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs), attributable risks, liability R2 values, and proportions mediated. RESULTS: Schizophrenia was associated with the polygenic risk score (OR, 8.01; 95% CI, 4.53-14.16 for highest vs lowest decile), socioeconomic status (OR, 8.10; 95% CI, 3.24-20.3 for 6 vs no exposures), and a history of schizophrenia/psychoses (OR, 4.18; 95% CI, 2.57-6.79). The R2 values were 3.4% (95% CI, 2.1-4.6) for the polygenic risk score, 3.1% (95% CI, 1.9-4.3) for parental socioeconomic status, and 3.4% (95% CI, 2.1-4.6) for family history. Socioeconomic status and psychiatric history accounted for 45.8% (95% CI, 36.1-55.5) and 25.8% (95% CI, 21.2-30.5) of cases, respectively. There was an interaction between the polygenic risk score and family history (P = .03). A total of 17.4% (95% CI, 9.1-26.6) of the effect associated with family history of schizophrenia/psychoses was mediated through the polygenic risk score. CONCLUSIONS AND RELEVANCE: Schizophrenia was associated with the polygenic risk score, family psychiatric history, and socioeconomic status. Our study demonstrated that family history of schizophrenia/psychoses is partly mediated through the individual's genetic liability.
IMPORTANCE: Schizophrenia has a complex etiology influenced both by genetic and nongenetic factors but disentangling these factors is difficult. OBJECTIVE: To estimate (1) how strongly the risk for schizophrenia relates to the mutual effect of the polygenic risk score, parental socioeconomic status, and family history of psychiatric disorders; (2) the fraction of cases that could be prevented if no one was exposed to these factors; (3) whether family background interacts with an individual's genetic liability so that specific subgroups are particularly risk prone; and (4) to what extent a proband's genetic makeup mediates the risk associated with familial background. DESIGN, SETTINGS, AND PARTICIPANTS: We conducted a nested case-control study based on Danish population-based registers. The study consisted of 866 patients diagnosed as having schizophrenia between January 1, 1994, and December 31, 2006, and 871 matched control individuals. Genome-wide data and family psychiatric and socioeconomic background information were obtained from neonatal biobanks and national registers. Results from a separate meta-analysis (34,600 cases and 45,968 control individuals) were applied to calculate polygenic risk scores. EXPOSURES: Polygenic risk scores, parental socioeconomic status, and family psychiatric history. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs), attributable risks, liability R2 values, and proportions mediated. RESULTS:Schizophrenia was associated with the polygenic risk score (OR, 8.01; 95% CI, 4.53-14.16 for highest vs lowest decile), socioeconomic status (OR, 8.10; 95% CI, 3.24-20.3 for 6 vs no exposures), and a history of schizophrenia/psychoses (OR, 4.18; 95% CI, 2.57-6.79). The R2 values were 3.4% (95% CI, 2.1-4.6) for the polygenic risk score, 3.1% (95% CI, 1.9-4.3) for parental socioeconomic status, and 3.4% (95% CI, 2.1-4.6) for family history. Socioeconomic status and psychiatric history accounted for 45.8% (95% CI, 36.1-55.5) and 25.8% (95% CI, 21.2-30.5) of cases, respectively. There was an interaction between the polygenic risk score and family history (P = .03). A total of 17.4% (95% CI, 9.1-26.6) of the effect associated with family history of schizophrenia/psychoses was mediated through the polygenic risk score. CONCLUSIONS AND RELEVANCE: Schizophrenia was associated with the polygenic risk score, family psychiatric history, and socioeconomic status. Our study demonstrated that family history of schizophrenia/psychoses is partly mediated through the individual's genetic liability.
Authors: S M Meier; E Agerbo; R Maier; C B Pedersen; M Lang; J Grove; M V Hollegaard; D Demontis; B B Trabjerg; C Hjorthøj; S Ripke; F Degenhardt; M M Nöthen; D Rujescu; W Maier; T Werge; O Mors; D M Hougaard; A D Børglum; N R Wray; M Rietschel; M Nordentoft; P B Mortensen; M Mattheisen Journal: Mol Psychiatry Date: 2015-09-01 Impact factor: 15.992
Authors: David T Liebers; Mehdi Pirooznia; Fayaz Seiffudin; Katherine L Musliner; Peter P Zandi; Fernando S Goes Journal: Schizophr Bull Date: 2016-02-12 Impact factor: 9.306
Authors: Daniel W Belsky; Avshalom Caspi; Louise Arseneault; David L Corcoran; Benjamin W Domingue; Kathleen Mullan Harris; Renate M Houts; Jonathan S Mill; Terrie E Moffitt; Joseph Prinz; Karen Sugden; Jasmin Wertz; Benjamin Williams; Candice L Odgers Journal: Nat Hum Behav Date: 2019-04-08
Authors: Dag Alnæs; Tobias Kaufmann; Dennis van der Meer; Aldo Córdova-Palomera; Jaroslav Rokicki; Torgeir Moberget; Francesco Bettella; Ingrid Agartz; Deanna M Barch; Alessandro Bertolino; Christine L Brandt; Simon Cervenka; Srdjan Djurovic; Nhat Trung Doan; Sarah Eisenacher; Helena Fatouros-Bergman; Lena Flyckt; Annabella Di Giorgio; Beathe Haatveit; Erik G Jönsson; Peter Kirsch; Martina J Lund; Andreas Meyer-Lindenberg; Giulio Pergola; Emanuel Schwarz; Olav B Smeland; Tiziana Quarto; Mathias Zink; Ole A Andreassen; Lars T Westlye Journal: JAMA Psychiatry Date: 2019-07-01 Impact factor: 21.596
Authors: Renato Polimanti; Chia-Yen Chen; Robert J Ursano; Steven G Heeringa; Sonia Jain; Ronald C Kessler; Matthew K Nock; Jordan W Smoller; Xiaoying Sun; Joel Gelernter; Murray B Stein Journal: J Neurotrauma Date: 2016-08-25 Impact factor: 5.269
Authors: Ashley E Nordsletten; Henrik Larsson; James J Crowley; Catarina Almqvist; Paul Lichtenstein; David Mataix-Cols Journal: JAMA Psychiatry Date: 2016-04 Impact factor: 21.596
Authors: William G Honer; Alejandro Cervantes-Larios; Andrea A Jones; Fidel Vila-Rodriguez; Julio S Montaner; Howard Tran; Jimmy Nham; William J Panenka; Donna J Lang; Allen E Thornton; Talia Vertinsky; Alasdair M Barr; Ric M Procyshyn; Geoffrey N Smith; Tari Buchanan; Mel Krajden; Michael Krausz; G William MacEwan; Kristina M Gicas; Olga Leonova; Verena Langheimer; Alexander Rauscher; Krista Schultz Journal: Can J Psychiatry Date: 2017-02-15 Impact factor: 4.356